High-Dose Vitamin C: Treatment Information
High-dose intravenous vitamin C delivers vitamin C directly into the bloodstream. NexGen Health offers physician-supervised vitamin C infusions in San Jose. Whether an infusion is appropriate depends on a review of your medical history, medications, and individual circumstances.
Understand the Evidence and Its Limits
Vitamin C is an essential nutrient. Delivering it intravenously can produce higher blood concentrations than taking it by mouth, but higher concentrations alone do not establish a clinical benefit. Research into high-dose IV vitamin C continues, and findings should not be presented as a promise of recovery, immune protection, or longer life.
Vitamin C and Cancer: An Important Distinction
The FDA has not approved IV vitamin C as a treatment for cancer. NexGen Health does not claim that vitamin C infusions cure cancer, cause remission, or replace oncology care. A patient’s improvement or scan results cannot, by themselves, establish that an infusion caused that outcome.
If you have cancer or are receiving treatment, discuss any proposed infusion or supplement with your oncology team before proceeding. See the National Cancer Institute’s overview of intravenous vitamin C for information about research, risks, and potential interactions.
Clinical Assessment Before Treatment
High-dose vitamin C is not appropriate for everyone. A clinician should assess relevant risks, including kidney problems, G6PD deficiency, iron-overload disorders, and medication interactions. Medical supervision does not eliminate treatment risks.
At your consultation, ask about the reason an infusion is being considered, the evidence for that use, potential adverse effects, alternatives, and any screening needed. Dosing and scheduling require an individual clinical assessment.
Frequently Asked Questions
High-dose vitamin C is not appropriate for everyone. A clinician should assess your medical history, kidney health, G6PD status, iron-overload risk, and medications before treatment. Medical supervision does not eliminate risk.
There is no universal schedule. Whether an infusion is appropriate, and any dose or frequency, should follow an individual clinical assessment and discussion of the evidence, risks, and alternatives.
IV vitamin C is not FDA-approved to treat cancer. It should not replace oncology care, and we do not claim it cures cancer or causes remission. Discuss any proposed infusion with your oncology team before proceeding.
Timing depends on the prescribed infusion and your clinical needs. Ask the care team how much time to allow for assessment, preparation, and monitoring.
Discuss Your Questions with the Care Team
Contact NexGen Health or call +1 (408) 400-2967 to ask about consultation availability.
Medically reviewed by James Petros, M.D., M.B.A. on